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Background: Analysis of single nucleotide polymorphisms (SNPs) derived from whole-genome studies allows for rapid
evaluation of genome-wide diversity, and genomic epidemiology studies of Plasmodium falciparum provide insights
into parasite population structure, gene flow, drug resistance and vaccine development. In areas with adequate cold
chain facilities, large volumes of leukocyte-depleted patient blood can be frozen for use in parasite genomic analyses.
In more remote endemic areas smaller volumes of infected blood are taken by finger prick, and dried and stored
on filter paper. These dried blood spots do not generally yield enough concentrated parasite DNA for whole-genome
sequencing.
Results: A DNA microarray was designed for use on field samples to type a genome-wide set of SNPs which prior
sequencing had shown to be variable in Africa, Southeast Asia, and Papua New Guinea. An algorithm was designed to
call SNPs in samples with low parasite DNA. With this new algorithm SNP-calling accuracy of 98% was measured by
hybridizing purified DNA from malaria lab strains and comparing calls with SNPs called from full genome sequences.
An average accuracy of >98% was likewise obtained for DNA extracted from malaria field samples collected in studies
in Southeast Asia, with an average call rate of > 82%.
Conclusion: This new high-density microarray provided high quality SNP calls from a wide range of parasite DNA
quantities, and represents a robust tool for genome-wide analysis of malaria parasites in diverse settings.
Keywords: Plasmodium falciparum, Malaria, MicroarrayBackground
Tools for assessing genetic diversity in malaria parasites
are of potential use for the discovery of novel malaria
vaccine antigens [1], and for understanding the molecu-
lar basis of drug resistance [2-6]. Recent advances in
genome sequencing technology offer high-throughput
methods for obtaining full genomic data [7,8]. However,
these technologies still require relatively large quantities
of high quality DNA. Microarrays are able to tolerate
DNA of lower quantity and quality typical of patient-
derived field samples, which contain far more human
than parasite DNA. Thus, field samples unsuitable for* Correspondence: cplowe@medicine.umaryland.edu
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unless otherwise stated.full-genome sequencing may be amenable to microarray
analysis. Microarrays can also be adapted to incorporate
new loci, determine copy number polymorphism or de-
signed to answer specific research questions.
Microarrays have been developed for genotyping
Plasmodium falciparum, using a variety of platforms
that detect single nucleotide polymorphisms (SNPs) at
loci that had been described at the time of platform
design [9-12]. Many novel SNPs were discovered in a
large scale P. falciparum sequencing project, resulting
in a map of population genomic variation [8]. We
sought to create a microarray that would be able to
genotype highly informative loci within this genomic
map in field samples that were not amenable to next-
generation sequencing. We also wanted a high-throughput
system capable of working with DNA extracted from lowtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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NimbleGen 4.2 million probe design in multi-plex for-
mat. This platform is comprised of 12 identical arrays
on one slide, each capable of genotyping 33,716 loci
within the P. falciparum genome. When dual-color la-
beling is used, two samples can be hybridized to a single
array yielding 33,716 SNPs for 24 samples in a single
2-day experiment, where several such slides can be run
simultaneously, making this approach relatively high-
throughput and inexpensive.Results
Heuristic base calling
To test the accuracy of this microarray we genotyped
cultured parasites of the 3D7 reference strain, simulating
varying levels of parasitemia by dilution into whole
blood and using various pre- and post-extraction process-
ing of the DNA. A previous P. falciparum array using the
same NimbleGen technology used a SNP-calling algo-
rithm referred to as the D-score method [9]. Applied to
the new array, this approach provided an average of >92%
accuracy for samples with 10,000 or more parasites/μl.
However, samples with low parasitemia (<1,000 parasites/
μl) yielded very poor accuracy (69% and 76%, Table 1).
Investigation of this inaccuracy identified a strong bias
toward G and C SNP calls in lower parasitemia samples
(Figure 1A). The cause of this bias is most likely a lack
of probe saturation in low DNA quantity samples and
inflated intensities due to a higher binding affinity of
the triple hydrogen bonding of guanine to cytosine.
The D-score method relies entirely on raw intensity
values to call SNPs, without regard to the base compos-
ition of the probe (Figure 1B). Many microarrays do
not rely on raw intensity values to make base calls, and
in some instances a complex model is fitted to the data
to accurately call SNPs [13,14]. To overcome this bias a
heuristic algorithm was developed which uses the probe
center base position to adjust raw intensity values
(Figure 1C). When applied to the samples describedTable 1 SNP call accuracy and SNP call rate of 3D7 cultured p
SNP call accuracy
Heuristic algorithm D-score method
WGA + - + -
LD + - + - + - +
1,000 p/μl 99.0 96.2 99.6 94.1 93.5 76.4 97.4
10,000 p/μl 99.4 99.4 99.7 99.5 94.4 95.8 98.6
100,000 p/μl - 99.6 - 99.7 - 98.7 -
500,000 p/μl - 99.7 - 99.8 - 98.4 -
To test the accuracy and call rate of the new heuristic algorithm cultured 3D7 strain
amplification, and parasite concentrations. We then compared the previously describe
LD= leukocyte depletion, p/μl = parasites per microliter).above, this new algorithm gave accuracies greater than
95% in nearly all samples tested.
This algorithm uses the global array average for probes
with identical center positions to adjust individual probe
intensities. A call is made only when the sense and anti-
sense base match, a contrast between alleles of 0.98 ex-
ists, and all intensities are greater than the random binding
threshold. This heuristic algorithm outperformed the
D-score method in the mixing experiment of cultured
3D7 parasites raising the average accuracy of these
samples to >98% and increasing the accuracy of the
1,000 parasites/μl by as much as 25%. We also observed
an increase in SNP call rates when using this heuristic
algorithm.
To set more accurate sample quality control (QC)
thresholds we switched from the initial approach of
measuring DNA quantity in terms of parasites/μl to a
quantitative PCR (qPCR) method. For the previous
microarray a DNA quantify cutoff of 250 ng was used
to select samples for testing, but lower input amounts
were not systematically evaluated [9]. Adopting the new
heuristic algorithm and using 152–219 ng DNA from
the NF54 parasite lab strain quantified using 18 s
qPCR, we observed an average SNP-calling accuracy of
99.4% (Table 2). To identify the lower limits of DNA
quantity we tested a range of 1–40 ng purified DNA
from 3D7 and Dd2 parasites, obtaining >95% accuracy
down to 20 ng of parasite DNA for 3D7 and down to
10 ng for Dd2. Calculation of call rates for all samples
revealed a wide range (8% - 70%) which was associated
with the amount of DNA used (p = 1.57e-05) (Figure 2).
For these samples there was also an association of DNA
quantity with call accuracy (p = 0.025).
Analysis of field isolates and leukocyte depletion
To assess the feasibility and accuracy of using DNA from
P. falciparum parasites extracted directly from patient
blood we used both high and low parasite DNA concen-
tration samples derived from venous blood samples that
had and had not been subjected to leukocyte depletion.arasites
SNP call rate
Heuristic algorithm D-score method
+ - + -
- + - + - + - + -
69.0 75.4 36.8 68.7 15.6 56.0 40.7 63.2 32.3
94.1 76.5 87.5 87.6 62.9 51.7 59.1 70.8 50.4
98.8 - 94.4 - 92.0 - 76.0 - 78.9
98.9 - 94.5 - 95.3 - 64.4 - 72.8
parasites were genotyped under differing leukocyte depletion, whole-genome
D-score method to the heuristic algorithm. (WGA=whole-genome amplification,
Figure 1 Sample intensities and intensity distributions of varying center bases. A) Distribution of raw probe intensities. Dotted lines
indicate global mean intensity values for T (black) and G (green) center position alleles. B) Average raw intensities of a single SNP for 24 field
samples. Dotted lines indicate area of low contrast where points between the lines would not be distinguishable. Black points were called a T
allele by genome sequencing and green diamonds were called a G allele. C) Average intensities after global mean adjustment, all sequenced
calls match microarray calls after running through algorithm.
Table 2 SNP call accuracy and SNP call rate of NF54
purified DNA
ID Parasite DNA (ng) Call accuracy Call rate
NF54-1 219 99.4% 86.6%
NF54-2 212 99.5% 81.5%
NF54-3 210 99.4% 78.6%
NF54-4 203 99.4% 73.8%
NF54-5 170 99.4% 85.7%
NF54-6 168 99.4% 77.3%
NF54-7 156 99.2% 76.9%
NF54-8 152 99.3% 69.0%
NF54 (WGA) 222 99.6% 91.6%
NF54 (WGA) 138 99.5% 85.1%
NF54 reference strain DNA was typed at varying concentrations and call accuracy
and call rate was calculated. Two samples underwent whole genome amplification
(WGA) prior to genotyping and the concentration reflects post-WGA quantities.
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Asia that had successfully undergone Illumina whole-
genome sequencing and had a parasite DNA concentra-
tion of 250 ng. These samples had an average accuracy of
98.4% and an average call rate of 85.4% (Figure 3A). Low
DNA volume samples were seven samples from Southeast
Asia that ranged from 206 ng down to 37 ng of parasite
DNA and averaged 98.8% and 73.9% accuracy and call rate
respectively. There was no correlation between accuracy
and DNA quantity (p = 0.79) (Figure 3B), while there was
a strong correlation (p = 9.8e-08) (Figure 3C) between
DNA quantity and call rate, demonstrating that DNA
quantity is a good predictor of the number of SNPs called.
Analyses were performed on all reference and field isolates
tested to determine the per SNP accuracy rate. Among all
33,716 SNPs typed by this array ~28,000 were called
correctly in 100% of samples analyzed. Only a small subset
(~200) was called incorrectly in all samples and ~600 were
not able to be called in any sample. Only SNPs called
Figure 2 SNP call accuracy and SNP call rate of low quantity reference DNA. Black and grey bars show SNP accuracy of purified 3D7 and
Dd2 strain parasites at low DNA quantities (1 – 40 ng). Lines show SNP call rate of each typed sample. DNA quantity was significantly associated
with SNP calling accuracy (p = 0.025), and DNA quantity with SNP call rate (p = 1.57e-05).
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sions of the heuristic base calling algorithm. Distribution
of inaccurate SNPs appears random through visual inspec-
tion of both their place within the genome and their lay-
out on the printed array.
We noted a difference for low volume samples that
had undergone leukocyte depletion to remove human
DNA prior to DNA extraction. Leukocyte depletion
removes human white blood cells from a whole blood
sample, enriching the final sample for red blood cells
which harbor the parasite and consequently their DNA. In
the analysis of cultured 3D7 parasites diluted in whole
blood a subset of samples were leukocyte depleted using
CF11 cellulose columns. For the 1,000 parasites/μl
samples we saw an average increase of accuracy of
4.2% and an average increase in SNP call rate of 45.9%
(Table 1). This increase was more pronounced in non-
whole genome amplified (WGA) samples.
Effects of whole-genome amplification
Samples with low DNA quantity can be subjected to
WGA to increase the amount of DNA, allowing more
samples to pass preliminary QC metrics. Several culturedand purified DNA samples underwent WGA prior to
genotyping and were used to evaluate possible bias when
undergoing amplification. Accuracies in cultured parasites
showed no marked difference (≤0.2%) while WGA slightly
increased the call rate overall (Table 1). Two NF54
DNA samples were subjected to WGA prior to microarray
analysis, yielding an average accuracy of 99.54% and an
average call rate of 88.34%, about 10% higher than the
non-WGA samples (Table 2).
Discussion
We set out to develop a SNP genotyping platform for
use on P. falciparum field samples of low DNA quantity
and quality, and evaluated this tool using parasite DNA
from cultured parasites and preserved venous blood col-
lected from malaria-infected individuals in field studies.
An earlier microarray used 250 ng of DNA as the mini-
mum level tested, although lower DNA quantities were
not systematically evaluated [9]. Our heuristic SNP-
calling algorithm was capable of accounting for a bias
discovered when using lower quantity samples and yields
highly accurate results for samples with as little as 37 ng
of parasite DNA in field samples and 10 ng in purified
Figure 3 SNP call accuracy and SNP call rate of field samples. A) SNP calling accuracy (grey bars) and SNP call rates (black line) for 24 field
isolate from Southeast Asia. B) Correlation of SNP call accuracy and DNA quantity (p = 0.79). C) Correlation of SNP call rate with DNA
quantity (p = 9.8e-08).
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paper samples, albeit with lower reproducibility (not
shown). Addition of a WGA step and a strict DNA quan-
tity threshold may improve reproducibility for filter paper
blood spots.
DNA microarrays have previously been used for SNP
detection in P. falciparum [9-11,15]. With the increased
availability of whole genome sequence data thanks to
lower costs and improved methodology, the value of
DNA microarrays can be questioned. However, for valu-
able field samples that are associated with important
demographic, clinical and other phenotypic data such as
drug resistance or vaccine resistance [16], microarrays
can rescue the high proportion of samples that fail to
meet criteria for sequencing, justifying the use of micro-
arrays. Samples that often do not meet sequencing stan-
dards include low volume blood samples, filter paper
blood spots, samples with high levels of human DNA
contamination, and archived or degraded samples. It was
our goal to create a SNP microarray that can comple-
ment genome sequence data in association and popula-
tion genetics studies, providing genome-wide SNP data
for samples not fit for sequencing. The SNPs chosenwere based on a set of highly validated loci identified by
sequencing hundreds of global isolates of P. falciparum
[8]. This large sequencing project shows how microar-
rays still have a place in genomic research. The first it-
eration of samples prepared for sequencing had a QC
pass rate of ~30%; more recent samples had a pass
rate of >50%. This leaves a significant number of sam-
ples with no data. By selecting SNPs from within this
highly validated list of loci we can fill in the gaps from
sequencing while continuing to use samples for which
sequencing was successful. The cost of genome-wide
microarray analysis (currently less than $90/sample
excluding personnel costs) compares favorably with
that of genome sequencing (at least 3-fold higher for
short-read Illumina sequencing and approximately
25-fold higher for third generation sequencing and assem-
bly). Imputation strategies are being developed that may
further increase the value of microarray-generated SNP
information.
Conclusions
This microarray genotypes over 33,000 variable positions
in the P. falciparum genome with high accuracy and high
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10 ng of parasite DNA increases the number of field
samples for which whole genome analysis is possible.
The selection of loci also allows samples genotyped on
this microarray to be analyzed in conjunction with
higher quality samples sequenced using next-generation
sequencing platforms.
Methods
SNP selection and chip design
A pooled set of all possible SNPs was gathered from
Version 1.0 of the MalariaGEN Community Project [8]
and a SNP set from an Affymetrix array used in a previ-
ous study [3]. This pooled set was filtered based on the
proportion of missing data in previous data sets, hyper-
heterozygosity, and minor allele-frequency (MAF) in
Southeast Asia and Africa ≥1%. SNPs were prioritized by
their MAF with precedence given to those with higher
MAF values. SNPs given the highest priority were those
that were variable in multiple populations. SNPs were
ranked in order of priority and then a final filter of mini-
mum inter-SNP distance was applied. To decrease theFigure 4 Microarray probe statistics. A) Histogram of Inter-SNP distance
where allele variability has been shown. C) Histogram of G + C content of pnumber of large genomic gaps lower priority SNPs were
given preference to high priority SNPs that were within
22 bp of another high priority SNP. The 22 bp value was
determined through systematically increasing the inter-SNP
distance threshold and measuring the number of large
genomic gaps and total number of loci.
SNPs from African and Southeast Asian parasites
were chosen to provide full coverage of the P. falciparum
genome (minus telemetric regions and hyper-variable var
gene clusters). Among the SNPs chosen for the array,
22,189 were variable only in Africa, 12,723 in Southeast
Asia, and 3,811 in Papua New Guinea. Among the SNPs
variable in Africa and Southeast Asia 6,007 were variable
on both continents. Also included on the array were 23
loci associated with drug resistance in the genes pfcrt,
pfmdr-1, pfdhps, and pfdhfr. The entire SNP set averaged
a median per chromosome inter-SNP distance of 324 bp
(Figure 4A).
The probes designed for the array were mostly low GC
content (Figure 4C) and of variable lengths (29–41 bp)
(Figure 4D). Variable length probes provide higher average
intensities when compared to static length probes and lows of all SNPs. B) Boxplot showing distribution of inter-SNP distances
robes. D) Histogram showing distribution of probe lengths.
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falciparum genome [9]. Standard NimbleGen probes
were also placed on the array, including alignment
probes, chip identification probes, and random cDNA
probes designed to match the content of our user de-
signed probes. The average intensity of 8,421 random
probes was used to define the global array background.
The NimbleGen 4.2 M Probe Custom DNA Microarray
comes in varying formats from which we selected the
highest number of plexes (12) to increase the number of
samples for use in high-throughput fields studies. Probe
length was determined by cDNA melting temperature of
the sequence surrounding each SNP. For every SNP there
were eight probes, four in the sense direction with each
base at the center position and four in the anti-sense
direction. Probe quartets were arranged sequential on
the array to avoid variation due to chip defects and
spatial bias. This array is no longer available as NimbleGen
has discontinued custom microarray production. Steps are
being taken to transfer this probe set and analysis pipeline
to a new commercial platform.
DNA labeling and hybridization
Sample DNA was concentrated using vacuum centrifu-
gation to a volume of 30–50 μl and heat denatured with
1 OD of 65% random nonamers labeled with cy3 or cy5
for 10 minutes at 98°C. Denatured DNA was chilled on
ice for 2 minutes and then incubated for 2 hours at 37°C
in the presence of 50 units of Klenow fragment and a
50X dNTP mixture. The reaction was terminated with
0.5 M EDTA and DNA were precipitated with 5 M NaCl
and iso-propanol. Labeled DNA was washed 2–3 times
with 80% ice cold ethanol to remove unincorporated
dye. After removal of ethanol, samples were rehydrated
in water and cy3 and cy5 labeled samples were combined
for multiplexing. Samples were vacuum-concentrated and
resuspended in a buffer containing NimbleGen alignment
oligo and 1X Denhardt’s solution. The samples were heat
denatured at 95°C for 5 minutes and stabilized at 42°C
prior to loading onto the array. Samples were hybridized
on a NimbleGen hybridization station for 16–24 hours at
42°C. Slides were disassembled in a dish containing Wash
Buffer 1 at 42°C and washed in Wash Buffer 1, Wash
Buffer 2, and Wash Buffer 3 for 2 minutes, 1 minute,
and 15 seconds respectively. Slides were washed and
subsequently dried in the SlideWasher 12 Array Process-
ing System. Microarrays were scanned with a NimbleGen
MS 200 Microarray Scanner at 2 μm using “autogain” to
automatically adjust scanning parameters on an individual
array basis.
Heuristic base calling algorithm
Each SNP typed by this array is at a bi-allelic locus, as de-
termined from extensive sequencing of global P. falciparumisolates [8]. The heuristic algorithm therefore focuses on
the two intensities of each possible allele. This algorithm
then identifies the global mean intensity for every probe
with the identical center base and adjusts each individual
intensity by the difference in intensity between the global
means of the two bases being interrogated. Intensities are
evaluated and adjusted independently for the sense and
anti-sense direction. After adjusting the intensity, a SNP is
called after fulfilling the following criteria: 1) the contrast of
intensities is greater than or equal to 0.98, 2) the forward
and reverse SNP calls are concordant, and 3) all intensities
are above global background levels determined by the aver-
age value of the random probes. Multiple thresholds were
tested for background levels up to average random plus
two standard deviations (data not shown). SNP calling ac-
curacy changed minimally when thresholds were raised,
however SNP call rate dropped more significantly. This
algorithm was written in the PERL programming language
and uses standard outputs from the Roche NimbleScan
(v2.6) software. Given the discontinuation of this micro-
array the algorithm will be made publically available when
the probe set is validated on a new platform.Experimental samples
P. falciparum (3D7 strain) was grown in culture under
standard conditions from stocks procured from the MR4
repository. Base parasitemia was determined by light mi-
croscopy and dilutions were made using human whole
blood. Dilutions were made to simulate 1,000, 10,000,
100,000, and 500,000 parasites/μl. Leukocyte depletion
was performed on a subset of samples using 2.5 mL of
blood in a CF11 column. Insufficient parasites were ac-
quired to fulfill the necessary 2.5 mL of blood for
leukocyte depletion of the 100,000 and 500,000 parasites/
μl mixture. DNA extraction of these samples was per-
formed with the Qiagen mini-kit. Dd2 and 3D7 puri-
fied DNA was also received from the MR4 repository.
Purified NF54 parasite DNA was generously donated
by Sanaria Inc. in Rockville MD. Whole blood samples
from field isolates came from studies conducted in
Southeast Asia [Takala-Harrison et al. under review].
A subset of samples was whole-genome amplified
prior to experimentation, for these samples we used a
Qiagen REPLI-g mini kit. Simple linear regression was
used to test the relationship of DNA quantity with
SNP call rate and SNP call accuracy. Informed consent
was obtained from participants or their parents or
guardians for samples collected as part of clinical trials
following protocols approved by the Research Ethics
Review Committee of the World Health Organization,
local Institutional Review Boards (IRBs), and samples
were analyzed following a protocol approved by the
University of Maryland, Baltimore IRB.
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The P. falciparum gene encoding the 18 s ribosomal
subunit was amplified using qPCR for each sample. In a
total reaction volume of 25 μl, 2 μl of sample DNA was
used along with 10 μM probe, 10 μM of each primer,
water, and TaqMan Universal PCR Master Mix (contain-
ing AmpliTaq Gold DNA Polymerase, dNTPs, and dUTP).
The sequences for primers and probe follows: Forward-
5′-GTA ATT GGA ATG ATA GGA ATT TAC AAG
GT-3′, Reverse- 5′-TCA ACT ACG AAC GTT TTA
ACT GCA AC-3′, Probe- 5′-FAM GAA CGG GAG
GTT AAC AA MGB-3′. PCR conditions were 15 minutes
at 95°C, 15 seconds at 95°C, and 45 cycles for 1 minute at
60°C. For quantification a standard curve was generated
and run on each plate as well as a no DNA control. Stand-
ard curve DNA was derived from purified NF54 parasite
DNA and quantified using CYBR Green. This DNA was
diluted to 3, 1.5, 0.75, 0.375, 0.188, 0.094, and 0.047 ng per
μl and each standard and sample was run in duplicate
with the final quantity expressed as the mean of both
values.Availability of supporting data
The data set supporting the results of this article is
available in the NCBI Gene Expression Omnibus data
repository, Accession: GSE56305, http://www.ncbi.nlm.
nih.gov/geo/.
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